Galanin and α-MSH autoantibodies in cerebrospinal fluid of patients with Alzheimer's disease
Alfredo Costa(University of Pavia), Sergueı̈ O. Fetissov(Inserm), Pierre Déchelotte(Inserm), Maria Hamze-Sinno(Institute for Research and Innovation in Biomedicine), Christine Bôle‐Feysot(Centre National de la Recherche Scientifique), Sabrina Ravaglia(University of Pavia), Tomas Hökfelt(Karolinska Institutet), Arrigo Moglia(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Paola Bini(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Diego Franciotta(Ospedale Santa Chiara), Elena Sinforiani(Fondazione Istituto Neurologico Nazionale Casimiro Mondino)
Cited by 25
Related Papers
Prevalence of eating disorders over the 2000–2018 period: a systematic literature review
|American Journal of Clinical Nutrition|2018|1.7k
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
|Journal of Neuroinflammation|2016|896
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
|Journal of Neuroinflammation|2018|740
Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype
|Gut|2014|483
Colonization of the Human Gut by <i>E. coli</i> and Colorectal Cancer Risk
|Clinical Cancer Research|2013|482